Neonatal mortality risk of large-for-gestational-age and macrosomic live births in 15 countries, including 115.6 million nationwide linked records, 2000-2020
Status Publisher Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu časopisecké články
Grantová podpora
1803-02535
Children's Investment Fund Foundation
PubMed
38012114
DOI
10.1111/1471-0528.17706
Knihovny.cz E-zdroje
- Klíčová slova
- fetal macrosomia, infant, large for gestational age, neonatal mortality, pregnancy,
- Publikační typ
- časopisecké články MeSH
OBJECTIVE: We aimed to compare the prevalence and neonatal mortality associated with large for gestational age (LGA) and macrosomia among 115.6 million live births in 15 countries, between 2000 and 2020. DESIGN: Population-based, multi-country study. SETTING: National healthcare systems. POPULATION: Liveborn infants. METHODS: We used individual-level data identified for the Vulnerable Newborn Measurement Collaboration. We calculated the prevalence and relative risk (RR) of neonatal mortality among live births born at term + LGA (>90th centile, and also >95th and >97th centiles when the data were available) versus term + appropriate for gestational age (AGA, 10th-90th centiles) and macrosomic (≥4000, ≥4500 and ≥5000 g, regardless of gestational age) versus 2500-3999 g. INTERGROWTH 21st served as the reference population. MAIN OUTCOME MEASURES: Prevalence and neonatal mortality risks. RESULTS: Large for gestational age was common (median prevalence 18.2%; interquartile range, IQR, 13.5%-22.0%), and overall was associated with a lower neonatal mortality risk compared with AGA (RR 0.83, 95% CI 0.77-0.89). Around one in ten babies were ≥4000 g (median prevalence 9.6% (IQR 6.4%-13.3%), with 1.2% (IQR 0.7%-2.0%) ≥4500 g and with 0.2% (IQR 0.1%-0.2%) ≥5000 g). Overall, macrosomia of ≥4000 g was not associated with increased neonatal mortality risk (RR 0.80, 95% CI 0.69-0.94); however, a higher risk was observed for birthweights of ≥4500 g (RR 1.52, 95% CI 1.10-2.11) and ≥5000 g (RR 4.54, 95% CI 2.58-7.99), compared with birthweights of 2500-3999 g, with the highest risk observed in the first 7 days of life. CONCLUSIONS: In this population, birthweight of ≥4500 g was the most useful marker for early mortality risk in big babies and could be used to guide clinical management decisions.
Clinical Epidemiology Division Department of Medicine Solna Karolinska Institutet Stockholm Sweden
Department of Clinical Epidemiology Aarhus University and Aarhus University Hospital Aarhus Denmark
Department of Wellness and Health Catholic University of Uruguay Montevideo Uruguay
Faculty of Health Sciences Catholic University of Maule Curicó Chile
Faculty of Medicine and Health University of Sydney Camperdown New South Wales Australia
Hamad Medical Corporation Doha Qatar
Mexican Society of Public Health Mexico City Mexico
Perined Utrecht the Netherlands
Pregnancy Birth and Child Health Team Public Health Scotland Edinburgh UK
Queen's Management School Queen's University Belfast Belfast UK
School of Natural and Built Environment Queen's University Belfast Belfast UK
Zobrazit více v PubMed
Abbas F, Kumar R, Mahmood T, Somrongthong R. Impact of children born with low birth weight on stunting and wasting in Sindh province of Pakistan: a propensity score matching approach. Sci Rep. 2021;11(1):19932.
Paixao ES, Blencowe H, Falcao IR, Ohuma EO, Rocha AS, Alves FJO, et al. Risk of mortality for small newborns in Brazil, 2011-2018: a national birth cohort study of 17.6 million records from routine register-based linked data. Lancet Reg Health Am. 2021; 3(100045): 1-8.
Katz J, Lee ACC, Kozuki N, Lawn JE, Cousens S, Blencowe H, et al. Mortality risk in preterm and small-for-gestational-age infants in low-income and middle-income countries: a pooled country analysis. Lancet. 2013;382(9890):417-425.
Fernández de Gamarra-Oca L, Ojeda N, Gómez-Gastiasoro A, Peña J, Ibarretxe-Bilbao N, García-Guerrero MA, et al. Long-term neurodevelopmental outcomes after moderate and late preterm birth: a systematic review. J Pediatr. 2021;237:168-176.e11.
Sacchi C, Marino C, Nosarti C, Vieno A, Visentin S, Simonelli A. Association of intrauterine growth restriction and small for gestational age status with childhood cognitive outcomes: a systematic review and meta-analysis. JAMA Pediatr. 2020;174(8):772-781.
Mayer C, Joseph KS. Fetal growth: a review of terms, concepts and issues relevant to obstetrics. Ultrasound Obstet Gynecol. 2013;41(2):136-145.
Practice bulletin no. 173: fetal macrosomia. Obstet Gynecol. 2016;128(5):e195-e209.
Beta J, Khan N, Khalil A, Fiolna M, Ramadan G, Akolekar R. Maternal and neonatal complications of fetal macrosomia: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2019;54(3):308-318.
Goldstein RF, Abell SK, Ranasinha S, Misso ML, Boyle JA, Harrison CL, et al. Gestational weight gain across continents and ethnicity: systematic review and meta-analysis of maternal and infant outcomes in more than one million women. BMC Med. 2018;16(1):153.
Scifres CM. Short- and long-term outcomes associated with large for gestational age birth weight. Obstet Gynecol Clin North Am. 2021;48(2):325-337.
Culliney KA, Parry GK, Brown J, Crowther CA. Regimens of fetal surveillance of suspected large-for-gestational-age fetuses for improving health outcomes. Cochrane Database Syst Rev. 2016;4(4):CD011739.
Magnusson Å, Laivuori H, Loft A, Oldereid NB, Pinborg A, Petzold M, et al. The association between high birth weight and long-term outcomes-implications for assisted reproductive technologies: a systematic review and meta-analysis. Front Pediatr. 2021;9:675775.
Hong YH, Lee JE. Large for gestational age and obesity-related comorbidities. J Obes Metab Syndr. 2021;30(2):124-131.
Boulet SL, Alexander GR, Salihu HM, Pass M. Macrosomic births in the United States: determinants, outcomes, and proposed grades of risk. Am J Obstet Gynecol. 2003;188(5):1372-1378.
Jamaluddine Z, Sharara E, Helou V, El Rashidi N, Safadi G, El-Helou N, et al. Effects of size at birth on health, growth and developmental outcomes in children up to age 18: an umbrella review. Arch Dis Child. 2023; 108:956-969.
World Health Organization. International Classification of Diseases, eleventh revision (ICD-11). Geneva: World Health Organization; 2022.
Bommarito PA, Cantonwine DE, Stevens DR, Welch BM, Davalos AD, Zhao S, et al. Fetal growth trajectories of babies born large-for-gestational age in the LIFECODES Fetal Growth Study. Am J Obstet Gynecol. 2023;228(3):340.e1-340.e20.
Zhao Y, Li DZ. Born large for gestational age: not just bigger. Am J Obstet Gynecol. 2023;228(3):366-367.
Younes S, Samara M, Salama N, Al-Jurf R, Nasrallah G, Al-Obaidly S, et al. Incidence, risk factors, and feto-maternal outcomes of inappropriate birth weight for gestational age among singleton live births in Qatar: a population-based study. PloS One. 2021;16(10):e0258967.
Hocquette A, Durox M, Wood R, Klungsøyr K, Szamotulska K, Berrut S, et al. International versus national growth charts for identifying small and large-for-gestational age newborns: a population-based study in 15 European countries. Lancet Reg Health Eur. 2021;8:100167.
Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report Percentage of large-for-gestational-age births, by race or hispanic ethnicity United States, 2005. 2008;57(12/12/2022):1258.
Villar J, Cheikh Ismail L, Victora CG, Ohuma EO, Bertino E, Altman DG, et al. International standards for newborn weight, length, and head circumference by gestational age and sex: the newborn cross-sectional study of the INTERGROWTH-21st Project. Lancet. 2014;384(9946):857-868.
Vieira MC, Relph S, Persson M, Seed PT, Pasupathy D. Determination of birth-weight centile thresholds associated with adverse perinatal outcomes using population, customised, and Intergrowth charts: a Swedish population-based cohort study. PLoS Med. 2019;16(9):e1002902.
Choi SKY, Gordon A, Hilder L, Henry A, Hyett JA, Brew BK, et al. Performance of six birth-weight and estimated-fetal-weight standards for predicting adverse perinatal outcome: a 10-year nationwide population-based study. Ultrasound Obstet Gynecol. 2021;58(2):264-277.
Koyanagi A, Zhang J, Dagvadorj A, Hirayama F, Shibuya K, Souza JP, et al. Macrosomia in 23 developing countries: an analysis of a multicountry, facility-based, cross-sectional survey. Lancet. 2013;381(9865):476-483.
Henriksen T. The macrosomic fetus: a challenge in current obstetrics. Acta Obstet Gynecol Scand. 2008;87(2):134-145.
Damhuis SE, Ganzevoort W, Gordijn SJ. Abnormal fetal growth: small for gestational age, fetal growth restriction, large for gestational age: definitions and epidemiology. Obstet Gynecol Clin North Am. 2021;48(2):267-279.
The International Fetal and Newborn Growth Consortium for the 21st Century. INTERGROWTH-21st 2020. [Cited June 2023]. Available from: https://intergrowth21.tghn.org/
Villar J, Giuliani F, Fenton TR, Ohuma EO, Ismail LC, Kennedy SH. INTERGROWTH-21st very preterm size at birth reference charts. Lancet. 2016;387(10021):844-845.
Papageorghiou AT, Ohuma EO, Altman DG, Todros T, Cheikh Ismail L, Lambert A, et al. International standards for fetal growth based on serial ultrasound measurements: the fetal growth longitudinal study of the INTERGROWTH-21st Project. Lancet. 2014;384(9946):869-879.
Ashorn P, Black RE, Lawn JE, Ashorn U, Klein N, Hofmeyr J, et al. The Lancet Small Vulnerable Newborn Series: science for a healthy start. Lancet. 2020;396(10253):743-745.
Suárez-Idueta L, Yargawa J, Blencowe H, Bradley E, Okwaraji YB, Pingray V, et al. Vulnerable newborn types: analysis of population-based registries for 165 million births in 23 countries, 2000-2021. BJOG. 2023:00:1-15.
Suárez-Idueta L, Blencowe H, Okwaraji YB, Yargawa J, Bradley E, Gordon A, et al. Neonatal mortality risk for vulnerable newborn types in 15 countries using 125.5 million nationwide birth outcome records, 2000-2020. BJOG. 2023;00:1-11.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
Ye W, Luo C, Huang J, Li C, Liu Z, Liu F. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2022;377:e067946.
Knight-Agarwal CR, Jani R, Al Foraih M, Eckley D, Lui CKW, Somerset S, et al. Maternal body mass index and country of birth in relation to the adverse outcomes of large for gestational age and gestational diabetes mellitus in a retrospective cohort of Australian pregnant women. BMC Pregnancy Childbirth. 2021;21(1):649.
Giudicelli M, Hassler M, Blanc J, Zakarian C, Tosello B. Influence of intrapartum maternal fluids on weight loss in breastfed newborns. J Matern Fetal Neonatal Med. 2022;35(4):692-698.
Wang D, Zhu L, Zhang S, Wu X, Wang X, Lv Q, et al. Predictive macrosomia birthweight thresholds for adverse maternal and neonatal outcomes. J Matern Fetal Neonatal Med. 2016;29(23):3745-3750.
Ye J, Torloni MR, Ota E, Jayaratne K, Pileggi-Castro C, Ortiz-Panozo E, et al. Searching for the definition of macrosomia through an outcome-based approach in low- and middle-income countries: a secondary analysis of the WHO Global Survey in Africa, Asia and Latin America. BMC Pregnancy Childbirth. 2015;15:324.
Chen HY, Chauhan SP, Ward TC, Mori N, Gass ET, Cisler RA. Aberrant fetal growth and early, late, and postneonatal mortality: an analysis of Milwaukee births, 1996-2007. Am J Obstet Gynecol. 2011;204(3):261.e1-261.e10.
Zhang X, Decker A, Platt RW, Kramer MS. How big is too big? The perinatal consequences of fetal macrosomia. Am J Obstet Gynecol. 2008;198(5):517.e1-517.e6.
Cnattingius S, Villamor E, Lagerros YT, Wikström AK, Granath F. High birth weight and obesity-a vicious circle across generations. Int J Obes (Lond). 2012;36(10):1320-1324.
Jolly MC, Sebire NJ, Harris JP, Regan L, Robinson S. Risk factors for macrosomia and its clinical consequences: a study of 350,311 pregnancies. Eur J Obstet Gynecol Reprod Biol. 2003;111(1):9-14.
Lu Y, Zhang J, Lu X, Xi W, Li Z. Secular trends of macrosomia in southeast China, 1994-2005. BMC Public Health. 2011;11:818.
Bjørstad AR, Irgens-Hansen K, Daltveit AK, Irgens LM. Macrosomia: mode of delivery and pregnancy outcome. Acta Obstet Gynecol Scand. 2010;89(5):664-669.
Pillai S, Cheyney M, Everson CL, Bovbjerg ML. Fetal macrosomia in home and birth center births in the United States: maternal, fetal, and newborn outcomes. Birth. 2020;47(4):409-417.
Macrosomia: ACOG practice bulletin, number 216. Obstet Gynecol. 2020;135(1):e18-e35.
Khan N, Ciobanu A, Karampitsakos T, Akolekar R, Nicolaides KH. Prediction of large-for-gestational-age neonate by routine third-trimester ultrasound. Ultrasound Obstet Gynecol. 2019;54(3):326-333.
Pilalis A, Souka AP, Papastefanou I, Michalitsi V, Panagopoulos P, Chrelias C, et al. Third trimester ultrasound for the prediction of the large for gestational age fetus in low-risk population and evaluation of contingency strategies. Prenat Diagn. 2012;32(9):846-853.
Chauhan SP, Rice MM, Grobman WA, Bailit J, Reddy UM, Wapner RJ, et al. Neonatal morbidity of small- and large-for-gestational-age neonates born at term in uncomplicated pregnancies. Obstet Gynecol. 2017;130(3):511-519.
Suárez-Idueta L, Pita R, Blencowe H, Barranco A, Gonzalez JF, Paixao ES, et al. National data linkage assessment of live births and deaths in Mexico: estimating under-five mortality rate ratios for vulnerable newborns and trends from 2008 to 2019. Paediatr Perinat Epidemiol. 2023;37(4):266-275.
Razaz N, John S, Joseph KS. The matrix revolutions: how databases and database linkages will transform epidemiologic research. Paediatr Perinat Epidemiol. 2023;37(4):287-291.
Mallouli M, Derbel M, Ingrid A, Sahli J, Zedini C, Ajmi T, et al. Associated outcomes to fetal macrosomia: effect of maternal diabetes. Tunis Med. 2017;95(2):120-125.